title: Thyroid function in patients with Alzheimer disease: implications on response to anticholinesterase treatment.
abstract: Increasing evidence supports an extensive interrelationship between thyroid hormones and the cholinergic system, which is selectively and early affected in Alzheimer disease (AD). The aim of the present study was to explore thyroid function in patients with AD before and after acetylcholinesterase inhibition treatment to possibly identify variances in response. Thyroid function tests were evaluated in 28 AD patients and 24 age and sex-matched controls. Nineteen of the patients were reevaluated after (4 mo) treatment with donepezil. Serum thyrotropin (TSH), triiodothyronine (T3), thyroxine (T4), the free fractions (fT3, fT4) and thyroid autoantibodies were determined using standard methods. All subjects were clinically euthyroid. Patients presented with higher fT4 and anti-thyroperoxidase levels, as compared with the controls. Significant reduction in T4, fT3, fT4, and anti-thyroperoxidase levels were observed 4 months after treatment. Responders had higher T4 and fT4, than nonresponders, followed by significant reductions after treatment. The above, within the normal range alterations, may represent a direct effect on hormone release from the thyroid gland and/or increased conversion of T4 to T3 within the brain. Higher T4 and fT4 levels before treatment might predict a favorable response to donepezil treatment.
authors.affiliation: Department of Neurology, School of Medicine, Athens National University, "Eginition" Hospital, 74 Vas. Sophias Avenue, Athens 11528, Greece. ekapaki@med.uoa.gr
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Kapaki
authors.forename: George P
authors.initials: GP
authors.lastname: Paraskevas
authors.forename: Emily
authors.initials: E
authors.lastname: Mantzou
authors.forename: Apostolos
authors.initials: A
authors.lastname: Papapostolou
authors.forename: Maria
authors.initials: M
authors.lastname: Alevizaki
authors.forename: Demetris
authors.initials: D
authors.lastname: Vassilopoulos
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D000077265:Donepezil; D005260:Female; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D008297:Male; D009483:Neuropsychological Tests; D010880:Piperidines / Q000627:therapeutic use; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000187:drug effects* / Q000502:physiology*; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
chemical_list: D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D014284:Triiodothyronine; D000077265:Donepezil; D013972:Thyrotropin; D013974:Thyroxine